Xeomin

Content Contributor

Incobotulinumtoxin A, is an additional chemical denervating compound that has the same mechanism of action as Botox. Since Xeomin does not have some of the additive proteins that Botox does, long-term users that have developed resistance to Botox may still be treatable with Xeomin. Traditionally, those who stop responding to Botox after repetitive treatments may consider a trail of Xeomin.

Learn More

Botox Chemical Denervation

Andrew Biello, MD, Frey Syndrome

Botox, aka Onabotulinumtoxin A, is an example of a chemical compound used in selective denervation. It is isolated from...

Frey Syndrome

Andrew Biello, MD, Frey Syndrome

Frey syndrome, also knowing gustatory sweating, is classically described in patients after parotidectomy surgery. It occurs as a result...

Selective Denervation

Andrew Biello, MD, Frey Syndrome

Selective denervation refers to the providers ability to select which neuron they would like to deem non functional. This...

Request A Topic

Couldn’t find the topic you were looking for? Let our contributors know and they will research your topic and help you discover any new medical technologies related to your diagnosis.

Request a new topic using the form below:

MEDcraze is a unique online community built by Patients, Clinicians and Industry.

If you have been recently diagnosed, or have an established medical condition, you can now obtain unprecedented access to technologies that address your medical circumstance. You can then take this information and have an elevated discussion, based on technology, with your healthcare provider.